Diabetes and thyroid-hormone-induced changes in cardiac function and their molecular basis

Area of Science:

• Endocrinology
• Cardiology
• Molecular Biology

Background:

• The heart is a key target for thyroid hormones and insulin, with significant functional changes observed in hyperthyroidism, hypothyroidism, and diabetes mellitus.
• Thyroid status influences cardiac contractility through direct hormonal effects, sympathoadrenal system modulation, and peripheral hemodynamic alterations.
• Diabetes mellitus contributes to significant cardiovascular morbidity and mortality, including a distinct cardiomyopathy independent of large vessel disease.

Purpose of the Study:

• To elucidate the mechanisms by which thyroid hormones and diabetes mellitus affect cardiac function.
• To investigate the role of specific contractile proteins in endocrine-related cardiomyopathies.
• To understand the metabolic underpinnings of diabetic cardiomyopathy.

Main Methods:

• Analysis of cardiac function and protein expression in animal models of diabetes.
• Assessment of cardiac contractility changes in hyperthyroid and hypothyroid states.
• Examination of hormonal and hemodynamic influences on the heart.

Main Results:

• Cardiac contractility is elevated in hyperthyroidism and reduced in hypothyroidism, associated with changes in contractile proteins.
• Diabetic cardiomyopathy, characterized by congestive heart failure, occurs independently of large vessel disease.
• Diabetic animal models suggest a metabolic basis for cardiomyopathy, with alterations in contractile proteins.

Conclusions:

• Thyroid status and diabetes mellitus profoundly alter cardiac function and structure.
• Specific contractile protein modifications are linked to endocrine-induced cardiac dysfunction.
• Metabolic derangements are central to the development of diabetic cardiomyopathy.